Real-world of AI in Diagnosing Retinal Diseases
Recruiting
Observational Study
Artificial Intelligence
Retinal Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100,000 (estimated)
- Sponsor
- Beijing Tongren Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to apply an artificial intelligence algorithm to diagnose multi-retinal diseases in real-world settings. The effectiveness and accuracy of this algorithm are evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* fundus photography around 45° field which covers optic disc and macula
* complete identification information
Exclusion Criteria:
* insufficient information for diagnosis
Contacts